Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2014 Feb 14;20(6):1630-4.
doi: 10.3748/wjg.v20.i6.1630.

Characterization of primary hepatic carcinosarcoma by contrast-enhanced ultrasonography: a case report

Affiliations
Case Reports

Characterization of primary hepatic carcinosarcoma by contrast-enhanced ultrasonography: a case report

Li-Ping Liu et al. World J Gastroenterol. .

Abstract

Primary hepatic carcinosarcoma is a rare tumor and is comprised of a mixture of carcinomatous and sarcomatous elements. We present a case of primary carcinosarcoma of the liver in a 59-year-old woman, which was confirmed by pathology following surgical resection. Using contrast-enhanced ultrasonography, the tumor showed peripheral nodular hyperenhancement in the arterial phase with two feeding arterial vessels and a large internal non-enhancing portion in the center. The peripheral nodular portion of the tumor showed hypoenhancement in the later phase.

Keywords: Carcinosarcoma; Contrast-agent; Liver; Ultrasonography.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Conventional ultrasonography of a primary hepatic carcinosarcoma. A: Gray-scale ultrasonography showed an ovoid heterogeneous echogenic mass in the right liver; B: Color doppler imaging showed the right hepatic vein compressed by the mass (arrow).
Figure 2
Figure 2
Contrast-enhanced ultrasonography of a primary hepatic carcinosarcoma. A: Contrast-enhanced sonography showed early intense peripheral nodular enhancement in the arterial phase (21 s) with two feeding arteries (arrows); B: Peripheral nodular portion of the tumor was iso-enhancing compared to the surrounding liver in the portal phase (76 s); C: Peripheral nodular portion of the tumor was washed out and was hypo-enhanced compared to the liver in the later phase (191 s).
Figure 3
Figure 3
Contrast-enhanced computed tomographic of a primary hepatic carcinosarcoma. A: Contrast-enhanced computed tomographic revealed peripheral nodular enhancement in the arterial phase with a large internal non-enhancing portion, which correlated with contrast-enhanced ultrasonography findings; B: Peripheral nodular portion of the tumor was isoenhanced in the portal phase.
Figure 4
Figure 4
Pathologic findings of the primary hepatic carcinosarcoma (hematoxylin and eosin, original magnification × 200). A: A section of the gross specimen showing a well-demarcated, peripheral nodular solid mass with a central area of necrosis and hemorrhage; B: Light microscopy showing moderate hepatocellular carcinoma; C: Stromal sarcoma components are comprised of spindle cells; D: Atypical spindle and epithelial cells are seen, which are consistent with hepatic carcinosarcoma.

References

    1. Ishak KG, Anthony PP, Sobin LH. Histological typing of tumours of the liver (WHO. World Health Organization. International Histological Classification of Tumours). 2nd ed. Berlin: Springer-Verlag; 1994. pp. 27–28.
    1. Lin YS, Wang TY, Lin JC, Wang HY, Chou KF, Shih SC, Chen MJ. Hepatic carcinosarcoma: clinicopathologic features and a review of the literature. Ann Hepatol. 2013;12:495–500. - PubMed
    1. Aparicio MA, Esteban C, Bengoechea O, Muñoz-Bellvís L. Primary carcinosarcoma of the liver: an unusual case with clearly separated epithelial and mesenchymal components. Rev Esp Enferm Dig. 2011;103:336–338. - PubMed
    1. Celikbilek M, Deniz K, Torun E, Artis T, Ozaslan E, Karahan OI, Patiroglu TE, Ozbakir O. Primary hepatic carcinosarcoma. Hepatobiliary Pancreat Dis Int. 2011;10:101–103. - PubMed
    1. Shu RY, Ye M, Yu WY. A case of primary liver carcinosarcoma: CT findings. Chin J Cancer. 2010;29:346–348. - PubMed

Publication types